Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Bone resorption is solely mediated by osteoclasts. Therefore, a pure osteoclast population is of high interest for the investigation of biological aspects of the osteoclasts, such as the direct effect of growth factors and hormones, as well as for testing and characterizing inhibitors of bone resorption. We have established a pure, stable, and reproducible system for purification of human osteoclasts from peripheral blood. We isolated CD14-positive (CD14+) monocytes using anti-CD14-coated beads. After isolation, the monocytes are differentiated into mature osteoclasts by stimulation with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappaB ligand (RANKL). Osteoclast formation was only observed in the CD14+ population, not in the CD14- population, and only in the presence of both M-CSF and RANKL, confirming that the CD14+ system is a pure population of osteoclast precursors. No expression of osteoclast markers was observed in the absence of RANKL, whereas RANKL dose-dependently induced the expression of cathepsin K, tartrate-resistant acid phosphatase (TRACP), and matrix metallo proteinase (MMP)-9. Furthermore, morphological characterization of the cells demonstrated that actin rings were only formed in the presence of RANKL. Moreover, the osteoclasts were capable of forming acidic resorption lacunae, and inhibitors of lysosomal acidification attenuated this process. Finally, we measured the response to known bone resorption inhibitors, and found that the osteoclasts were sensitive to these and thereby provided a robust and valid method for interpretation of the effect of antiresorptive compounds. In conclusion, we have established a robust assay for developing osteoclasts that can be used to study several biological aspects of the osteoclasts and which in combination with the resorption marker CTX-I provides a useful tool for evaluating osteoclast function in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MOs stimulated with RANKL and M-CSF generate functional OCs [27], which degrade bone and express OC markers [28].”
From PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation (2013) · cites this paper as [28]
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
Bowman, E. J., Siebers, A., & Altendorf, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.7972 · Cited by 1,784
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
(2020) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,683
Principles of Bone Biology: By Bilezikian, Raisz and Rodan. Academic Press, London, U.K., 1996
Compston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,370
Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., & Tashiro, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47429-2 · Cited by 1,328
Research works printed but not linked: 7
- GR Mundy, 1996, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 16
- T Suda, 1996, Principles of Bone Biology, 87
- R Baron, 1986, Am J Pathol, 122, 363
- K Väänänen, 1996, Principles of Bone Biology, 103
- SC Manolagas, 2000, Endocr Rev, 21, 115
- M Horton, 1990, J Exp Pathol, 71, 741
- Y Okada, 1995, Lab Invest, 72, 311
Cited by
Items 101–142 of 142
Communication between the skeletal and immune systems
Lee, S. H., & Choi, Y. (2015) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2015.09.004 · Cited by 12
de Mendoza, I. L., Marichalar‐Mendía, X., Setien‐Olarra, A., García-De-La-Fuente, A.-M., Llamosas, R. M.-C., & Aguirre‐Urizar, J. M. (2024) · BMC Oral Health · doi:10.1186/s12903-024-04319-1 · Cited by 10
A New Method to Sort Differentiating Osteoclasts into Defined Homogeneous Subgroups
Hulley, P. A., & Knowles, H. J. (2022) · Cells · doi:10.3390/cells11243973 · Cited by 11
“Not all of the precursor cell pool responds to the differentiation cytokines, and both murine [14,15] and human [13,16,17] osteoclast preparations contain a mixed population of undifferentiated and mononuclear cells, binuclear pre-osteoclasts and multinucleated osteoclasts at different stages of fusion (3–20+ nuclei).”
BackgroundJagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis
Ng, C., Qin, Y., Xia, Y., Hu, X., & Zhao, B. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300317 · Cited by 8
Kylmäoja, E., Nakamura, M., Kokkonen, H. E., Ronkainen, V., Lehenkari, P. P., & Tuukkanen, J. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e00621 · Cited by 8
“Several studies have shown that RANKL and M-CSF alone are sufficient to induce osteoclastogenesis from PB monocytes [17, 18, 64], but other studies highlight the importance of TGF-b as a costimulating agent in osteoclastogenesis both from PB and BM monocytes [9, 10].”
ResultUpscaling Osteoclast Generation by Enhancing Macrophage Aggregation Using Hollow Microgels
Husch, J. F. A., Araújo‐Gomes, N., Willemen, N. G. A., Cofiño‐Fabrés, C., van Creij, N., Passier, R. C., Leijten, J., & van den Beucken, J. J. J. P. (2024) · Small · doi:10.1002/smll.202403272 · Cited by 7
Schoenmaker, T., Botman, E., Sariyildiz, M., Micha, D., Netelenbos, J. C., Bravenboer, N., Kelder, A., Eekhoff, E. M. W., & de Vries, T. J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00501 · Cited by 9
Todorov, A., Scotti, C., Barbero, A., Scherberich, A., Papadimitropoulos, A., & Martín, I. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2016.0553 · Cited by 7
“To test this hypothesis, we sorted monocytes from peripheral blood 12,13 and primed them to osteoclastogenesis through stimulation with RANKL and macrophage colony-stimulating factor (M-CSF).”
Aging and menopause reprogram osteoclast precursors for aggressive bone resorption
Møller, A. M. J., Delaissé, J.-M., Olesen, J. B., Madsen, J. S., Canto, L. M., Bechmann, T., Rogatto, S. R., & Søe, K. (2020) · Bone Research · doi:10.1038/s41413-020-0102-7 · Cited by 6
Engineering osteoclast resorption units via sacrificial microgels in a bone-on-chip platform
Conceição, F., Araújo‐Gomes, N., Husch, J. F. A., Becker, M., van den Beucken, J. J. J. P., Leijten, J., & Teixeira, L. M. (2025) · Lab on a Chip · doi:10.1039/d5lc00682a · Cited by 8
Wookey, P. J. (2009) · The Open Zoology Journal · Cited by 6
Osteoclasts-Key Players in Skeletal Health and Disease
Novack, D. V., & Mbalaviele, G. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch13 · Cited by 8
Cramer, E. E. A., de Wildt, B. W. M., Hendriks, J. G. E., Ito, K., & Hofmann, S. (2023) · Bone · doi:10.1016/j.bone.2023.116935 · Cited by 7
Ferro, F., Spelat, R., D’Aurizio, F., Falini, G., Pol, I. D., Pandolfi, M., Beltrami, A. P., Cesselli, D., Beltrami, C. A., & Curcio, F. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0411 · Cited by 5
“At the same time the presence of mononucleated cells and the absence of RANK, CD14, and calcitonin receptor 19,26 expression allow us to exclude the presence of progenitor or mature osteoclastic cells.”
Skjøt‐Arkil, H., Barascuk, N., Larsen, L., Dziegiel, M. H., Henriksen, K., & Karsdal, M. A. (2011) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0366 · Cited by 7
“The method of isolation of CD14 + monocytes and differentiation into macrophages has been successful at deriving osteoclasts, 35 for which reason this method was employed.”
InfluentialSelf-citationAutomated Quantification of Human Osteoclasts Using Object Detection
Kohtala, S., Nedal, T. M. V., Kriesi, C., Moen, S. H., Ma, Q., Ødegaard, K. S., Standal, T., & Steinert, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.941542 · Cited by 5
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Cen, W., Reinert, S., Avci‐Adali, M., Alexander, D., & Umrath, F. (2022) · Journal of Visualized Experiments · doi:10.3791/64016 · Cited by 10
Vallone, V. B. F., Borzone, F. R., Martinez, L. M., Giorello, M. B., Choi, H., Dimase, F., Feldman, L. J., Bordenave, R. H., Chudzinski‐Tavassi, A. M., Batagelj, E., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1073793 · Cited by 6
“BCPs (n=4) vs HVs (n=8) p BCPs (n=5) vs HVs (n=5) p RANK 2.70 ± 0.84 1.14 ± 0.48 NS 24.72 ± 7.27 3.15 ± 0.68 0.0419c CD51/61 22.07 ± 7.63 10.27 ± 4.23 NS 53.22 ± 14.04 56.63 ± 9.78 NS CD11b 45.30 ± 6.54 24.51 ± 5.00 0.0485a 66.20 ± 6.83 84.79 ± 1.32 NS CD14 21.83 ± 4.82 7.93 ± 2.37 0.0485b 67.47 ± 6.83 66.76 ± 0.87 NS…”
BackgroundMethodInfluentialMelphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
Byrgazov, K., Lind, T., Rasmusson, A. J., Andersson, C. R., Slipicevic, A., Lehmann, F., Gullbo, J., Melhus, H., Larsson, R. L., & Fryknäs, M. (2021) · Bone Reports · doi:10.1016/j.bonr.2021.101098 · Cited by 4
Schoenmaker, T., Zwaak, J., Loos, B. G., Volckmann, R., Köster, J., Eekhoff, E. M. W., & de Vries, T. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076822 · Cited by 5
“Osteoclasts arise through the fusion of the mononuclear hematopoietic precursor stem cells located in the bone marrow and peripheral blood [10,11].”
BackgroundFrom Development, Disease, and Decline: A Review of What Defines an Osteoclast Progenitor
Shimak, M. J., Kim, G., Karkache, I. Y., Vu, E. K., Chavez, E., Manser, J. C., Patterson, E. S., Basak, A., Vu, K. L., Mitchell, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110619 · Cited by 4
Proteomic Analysis of BMAC from the Iliac Crest and Humeral Head Using Support Vector Machines
Herna, C., Cipriani, M., Zhang, Y., Sachdev, R., & Jedlicka, S. S. (2025) · ACS Omega · doi:10.1021/acsomega.5c03945 · Cited by 1
Duan, S., Dang, Y., Rajani, G. M., Kis‐Tóth, K., & Salas, J. (2022) · Frontiers in Hematology · doi:10.3389/frhem.2022.1020852 · Cited by 1
MARKERS OF BONE TURNOVER IN PRECLINICAL DEVELOPMENT OF DRUGS FOR SKELETAL DISEASES
Rissanen, J. P. (2013) · UTUPub (University of Turku) · Cited by 4
Effect of microstructural and chemical cues on the in vitro cell response to calcium phosphates
Sadowska, J. M. (2018) · UPCommons institutional repository (Universitat Politècnica de Catalunya) · doi:10.5821/dissertation-2117-167835 · Cited by 3
“Hence, the appropriate pore size and interconnectivity leads to better new vessel formation.99,100 Xiao et al. showed that β-TCP scaffolds with high interconnected porosity favour the adhesion, migration and proliferation of human umbilical vein endothelial cells (HUVEC) and upregulates the expression of platelet and…”
BackgroundResultInfluentialZebrafish scales in bone research
de Vrieze, E. (2014) · Radboud Repository (Radboud University) · doi:10.13140/2.1.3475.7443 · Cited by 2
Salmon Calcitonin in the Treatment of Osteopor osis
Goel, A. K. (2010)
The role of the tumor suppressor PTEN in bone homeostasis
Arsenault, M. G. (2008) · eScholarship@McGill (McGill) · doi:10.82308/12655
The influence of modified chitosan substrates on osteoclastogenesis
Torres, A. L. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/e4jq-ms17 · Cited by 1
Sun, Y. (2009) · UTUPub (University of Turku)
Huang, X., Su, P., & Li, W. (2016) · Archives of Biological Sciences · doi:10.2298/abs150929057h
“Based on this rationale, a specific marker protein indicative of osteoclast differentiation (Cathepsin K) was selected to identify osteoclasts [17] while also ensuring the trend to inhibit osteoblast differentiation (Sp7) [18].”
BackgroundYang, L. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.008
RetractedCramer, E. E. A., de Wildt, B. W. M., Hendriks, J. G. E., Ito, K., & Hofmann, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.08.552563
Yu, Y., Yao, P., Wang, Z., & Xie, W. (2020) · Figshare · doi:10.6084/m9.figshare.12650316
Blümke, A., Ijeoma, E., Simon, J., Wellington, R., Purwaningrum, M., Doulatov, S. R., Leber, E., Scatena, M., & Giachelli, C. M. (2024) · Figshare · doi:10.6084/m9.figshare.26637021
Blümke, A., Ijeoma, E., Simon, J., Wellington, R., Purwaningrum, M., Doulatov, S. R., Leber, E., Scatena, M., & Giachelli, C. M. (2024) · Figshare · doi:10.6084/m9.figshare.26637018
Yu, Y., Yao, P., Wang, Z., & Xie, W. (2020) · Figshare · doi:10.6084/m9.figshare.12650313
Blümke, A., Ijeoma, E., Simon, J., Wellington, R., Purwaningrum, M., Doulatov, S. R., Leber, E., Scatena, M., & Giachelli, C. M. (2024) · Figshare · doi:10.6084/m9.figshare.26637015
Mun, S. H., Oh, B., Yokota, S., Umemoto, A., Suh, A. J., Kang, K., Kim, W., Oliver, D., Pannellini, T., Kwon, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.11.705073
“As osteoclasts are derived from synovial fluid (SF) CD14+ macrophages of patients with RA 36 , the expression of TACE in SF CD14+ macrophages was assessed.”
Silva, A. N. A., de Oliveira, G., Rodrigues, L. D. A., Mingatto, M. E. F., Gouvea, L. C., Sasso‐Cerri, E., & Cerri, P. S. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119871
Metadata
- Authors
- Sørensen, M. G., Henriksen, K., Schaller, S., Henriksen, D. B., Nielsen, F. C., Dziegiel, M. H., & Karsdal, M. A.
- Affiliations
- Nordic Bioscience (Denmark) (DK)
- Copenhagen University Hospital (DK)
- Corresponding author
- Karsdal, Morten Asser
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2006-12-26
- Volume
- 25
- Issue
- 1
- Pages
- 36-45
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W2094539147
- Cited by
- 143
- References
- 71
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- osteoclasts, osteoclastogenesis, CD14+ monocytes, bone resorption, RANKL, macrophage colony-stimulating factor, osteoclast precursors, cathepsin K, tartrate-resistant acid phosphatase, MMP-9, resorption lacunae, lysosomal acidification, antiresorptive agents, C-terminal telopeptide of type I collagen
- MeSH terms
- Animals, Blood, Cattle, Cell Differentiation, Female, Humans, Monocytes, Osteoclasts, Lipopolysaccharide Receptors, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.